ABSTRACT
The over-riding premise for biotechnology in this book is bringing novel products to market to substantially advance patient care and disease mitigation. Biotechnology, over its relatively brief existence of 40 years, has experienced a mercurial growth. The vast educational need for biotechnology information in this rapidly burgeoning field is a basic rationale here. However a more prominent underpinning is that, bringing biotech products to market for patient care involves success in the following four areas of engagement simultaneously - scientific advances for healthcare technologies, novel and varied products for untreated diseases, regulatory authorities, and biotech companies.
Features
- Comprehensive coverage of biotechnology science topics used in development and manufacturing
- Addresses all the scientific technologies within biotechnology responsible for products on the market and the pipeline
- Presents business issues such as marketing and sales of the products, as well as companies engaged, and how biotech business has evolved
TABLE OF CONTENTS
chapter chapter four|14 pages
The science of biotechnology
Peptides, vaccines, cell and tissue therapy, liposomes, nanobiotechnology, animal-sourced products
chapter chapter five|15 pages
The science of biotechnology
Molecular engineering (proteins, monoclonal antibodies, biosimilars)
